Results 241 to 250 of about 18,220 (284)

Omalizumab in treatment-resistant chronic spontaneous urticaria

Indian Journal of Dermatology, 2011
openaire   +3 more sources

Increased Cardiovascular Risk in Chronic Spontaneous Urticaria: A Large Real-World Cohort Study. [PDF]

Allergy
Curman P, Thaçi D, Ludwig RJ.
europepmc   +1 more source

Is it possible to use complete blood collection based systemic inflammatory indices as potential biomarkers for chronic spontaneous urticaria. [PDF]

Front Immunol
Li B, Peng L, Li R, Shi M, Li Y, Sun C, Zhang Z, Xue J, Zhao Y.   +8 more
europepmc   +1 more source

Co-existence of chronic spontaneous urticaria with atopic dermatitis: clinical and immunological perspectives. [PDF]

Front Allergy
Toubi E, Mubariki R, Vadasz Z.
europepmc   +1 more source

Successful treatment of chronic spontaneous urticaria and bladder pain syndrome with montelukast and/or omalizumab: a case report. [PDF]

J Med Case Rep
Bulut G.
europepmc   +1 more source

Nanomaterials in Targeted Immunotherapy for Chronic Spontaneous Urticaria: Focusing on Immune Cell Modulation and Precision Treatment. [PDF]

Int J Nanomedicine
Yao W, Peng C, He Y, Yang G, Luo D, Zhang Z, Chen L, Huang X.   +7 more
europepmc   +1 more source

Baseline Monocyte Count Predicts Complete Response to Omalizumab in Chronic Spontaneous Urticaria: A Retrospective Analysis. [PDF]

Cureus
Turhan İD, Solak B.
europepmc   +1 more source

Model-Informed Drug Development for Ligelizumab in Patients With Chronic Spontaneous Urticaria. [PDF]

CPT Pharmacometrics Syst Pharmacol
Bienczak A, Gautier A, Hua E, Ji Y, Scosyrev E, Smeets S, Severin T, Drollmann A, Patekar M, Savelieva M.   +9 more
europepmc   +1 more source